Randomized, Double-Blind Six-Month Trial of Prednisone in Duchenne's Muscular Dystrophy
Jerry R. Mendell(Nationwide Children's Hospital), Beverly Gilder, Gerald M. Fenichel(Vanderbilt University), Kenneth K. Kaiser, Stephen Mandel(Washington University in St. Louis), Cynthia L. Arfken, L. Signore(The Ohio State University), S. Pandya(Strong Memorial Hospital), Justin Robison(Vanderbilt University), Richard T. Moxley(MACOM (United States)), Julaine Florence, Jeanine Schierbecker, Wendy King(The Ohio State University), J. Philip Miller(Washington University in St. Louis), Michael H. Brooke, Robert C. Griggs(University of Rochester)
Cited by 518
Related Papers
Evidence‐based path to newborn screening for duchenne muscular dystrophy
|Annals of Neurology|2012|816
Eteplirsen for the treatment of Duchenne muscular dystrophy
|Annals of Neurology|2013|793
Dystrophin Immunity in Duchenne's Muscular Dystrophy
|New England Journal of Medicine|2010|655
Clinical trial in duchenne dystrophy. I. The design of the protocol
|Muscle & Nerve|1981|563
Myoblast Transfer in the Treatment of Duchenne's Muscular Dystrophy
|New England Journal of Medicine|1995|522